US2003021881A1PendingUtilityA1
Homogenous solid matrix cotaining vegetable proteins
Priority: Feb 23, 2000Filed: Feb 8, 2001Published: Jan 30, 2003
Est. expiryFeb 23, 2020(expired)· nominal 20-yr term from priority
Inventors:Doron Friedman
A61K 9/1617A61K 9/1658
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a homogenous solid matrix composition, enabling an improved dispersion of and bitter taste masking of hydrophobic, bioactive ingestibles, of at least low water solubility comprising: (a) at least 10 % w/w vegetable proteins; (b) lecithin; and (c) at leaset one ingestible bioactive compound of at least low water solubility.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A homogeneous solid matrix composition, enabling an improved dispersion of and bitter taste masking of hydrophobic, bioactive ingestibles, of at least low water solubility comprising:
(a) at least 10% w/w vegetable proteins; (b) lecithin; and (c) at least one ingestible bioactive compound of at least low water solubility.
2 . A composition of claim 1 , comprising lecithin and said ingestible bloactive compound in relative amounts of 1:3 to 3:1,
3 . A composition of claim 1 , comprising lecithin and said ingestible bioactive compound in relative amounts of 1:1.
4 . A composition of claim 2 , wherein the ratio of vegetable protein to the combined amounts of lecithin and ingestible bioactive compound is between 20:1 to 1:2.
5 . A composition of claim 2 , wherein the ratio of vegetable protein to the combined amounts of lecithin and ingestible bioactive compound is between 4:1 to 1:1.
6 . A composition of claim 1 , wherein said ingestible bioactive compound has a water solubility of less then 0.5 mg/ml at 25° C.
7 . The composition of claim 1 , wherein said vegetable proteins are selected from isolated and concentrated soybean proteins, containing at least 50% protein wherein the average MW of said proteins is larger then 25K Dalton.
8 . The composition of claim 1 , wherein said vegetable proteins are selected from isolated and concentrated soybean proteins, containing at least 60% proteins and said proteins are non-denatured.
9 . The composition of claim 1 , wherein said vegetable proteins are soybean proteins, containing at least 60% proteins and having a nitrogen solubility index (NSI) of at least 20%.
10 . composition of claim 1 , wherein said vegetable proteins are soybean proteins, containing at least 70% proteins and wherein the average MW of said proteins is larger then 25K Dalton and the NSI thereof is higher then 20%.
11 . The composition of claim 1 , wherein said vegetable proteins are selected from the group consisting of concentrated and isolated proteins of: corm potatoes, wheat, peanuts, beans, rice, sesame, barley, sunflower, canola and rapeseed.
12 . The composition of claim 1 , wherein ingestible bioactive compound is selected from the group consisting of a drug, a nutrient, a vitamin, a food supplement and mixtures thereof.
13 . A composition of claim 1 , wherein said ingestible bioactive compound is an herbal extract containing low water soluble ingredients.
14 . A method for preparing the composition of claim 1 , wherein lecithin is swollen in water in a ratio of between about 1:2 to 1:10 and said ingestible bioactive compound is added until complete solubilization, vegetable protein is then added with additional water to produce granulation dough, whereafter, the wet mass is granulated and dried.
15 . A method of claim 14 , wherein said wet mass is further diluted with water and spray dried.
16 . A method according to claim 14 , wherein the wet granulation is extruded through a screen having openings of 0.5 mm to 2.5 mm and spheronized in a spheronizer.
17 . A method according to claim 14 , wherein said ingestible bioactive compound is a bitter tasting compound and homogeneous particles and taste masking are obtained.
18 . A method according to claim 14 , in which the wet granulation is prepared and formed into spheres, utilizing a high shear granulator to form taste-masked spheres.
19 . The composition of claim 1 , wherein the limiting step for the ingestible bioactive compound release is the proteins gasto-intestinal digestion and decomposition of the matrix.
20 . The composition of claim 1 , wherein ingestible bioactive compound is released over period of one to three hours in the gastrointestinal tract.
21 . A composition of claim 1 , which is further coated or encapsulated.
22 . A core compound encapsulated with the homogenous matrix of claim 1 , in fluidized bad or spray drying process.Join the waitlist — get patent alerts
Track US2003021881A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.